Manufacturing / Pharmaceutical Preparations
Travere Therapeutics, Inc.
TVTX
$66.25
+$1.02 (+1.57%)
Price as of Aug 25, 2026 16:05 UTC
6.1 B
Market Cap (Mid Cap)
Oct 28
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for TVTX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
85 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Inrig Jula | Gift | 468 | $0 | |
| Jun 12, 2026 | Coughlin Timothy | Exercise | 10,000 | $265,200 | |
| Jun 12, 2026 | Coughlin Timothy | Sell | 10,000 | $500,747 | |
| Jun 12, 2026 | Coughlin Timothy | Exercise | 10,000 | $0 | |
| Jun 12, 2026 | Baynes Roy D. | Exercise | 4,500 | $96,210 | |
| Jun 12, 2026 | Baynes Roy D. | Sell | 4,500 | $225,000 | |
| Jun 12, 2026 | Baynes Roy D. | Exercise | 4,500 | $0 | |
| May 19, 2026 | Baynes Roy D. | Grant | 12,000 | $0 | |
| May 19, 2026 | Baynes Roy D. | Grant | 4,000 | $0 | |
| May 19, 2026 | Poole Sandra | Grant | 12,000 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 04, 2026 | Q2 2026 | -$0.14 | |||
| Jul 30, 2026 | Q2 2026 | -$0.14 | |||
| Mar 31, 2026 | Q1 2026 | -$0.27 | -$0.40 | -47.7% | Miss |
| Dec 31, 2025 | Q4 2025 | -$0.12 | $0.03 | +124.9% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.21 | $0.28 | +232.1% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.30 | -$0.14 | +53.9% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.55 | -$0.47 | +14.7% | Beat |
Track TVTX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for TVTX and your entire portfolio.